PRL-S1 5 MG
PRL-S1 is Peptiva Research Labs' house designation for a synthetic long-acting receptor-agonist peptide in the semaglutide research class, engineered to selectively activate the glucagon-like peptide-1 (GLP-1) receptor, a class B G-protein-coupled receptor. Structural modifications associated with this class are typically intended to extend molecular half-life, making PRL-S1 a useful reference tool for studying sustained single-receptor incretin signaling. In laboratory settings, researchers study PRL-S1 in receptor-binding and cyclic-AMP reporter assays, transfected cell lines, and preclinical models to characterize GLP-1 receptor activation, signaling kinetics, and gene-expression responses associated with appetite and glucose-homeostasis circuits. In-vitro work also examines receptor internalization, beta-arrestin recruitment, and the durability of signaling output relevant to long-acting agonist design. These investigations are mechanistic and exploratory, with no therapeutic, weight-loss, or veterinary intent. Peptiva Research Labs supplies it as a research-grade reference compound, HPLC-verified with a COA available. For Research Use Only, not for human or veterinary use.
Read the research guide: PRL-S1 (Semaglutide-Class GLP-1 Agonist): Research Overview →
Frequently asked questions
What is PRL-S1?
What receptor mechanism does PRL-S1 represent?
How is PRL-S1 stored and reconstituted?
Loading full product details…